HSII · As filed with the SEC
Heidrick & Struggles International cash flow statement, by quarter
The statement as Heidrick & Struggles International presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS · USD thousands
| USD thousands | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash flows - operating activities | ||||||||
| Net income | 17,646† | 21,073† | 13,306 | (14,976)† | 14,829† | (5,157)† | 14,032 | 14,855† |
| Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 5,383† | 5,015† | 4,847 | 5,207† | 4,950† | 3,910† | 4,790 | 5,076† |
| Deferred income taxes | — | — | — | — | 273† | (2,246)† | (87) | — |
| Deferred income taxes | (198)† | 509† | (1,883) | (17,361)† | 273† | (2,246)† | — | — |
| Stock-based compensation expense | 2,919† | 3,987† | 2,510 | 2,824† | 3,792† | 3,465† | 2,644 | 3,499† |
| Accretion expense related to earnout payments | 517† | 536† | 481 | 513† | 478† | 469† | 466 | 457† |
| Gain on marketable securities | (1,810)† | (1,702)† | (948) | (340)† | (1,343)† | (441)† | (539) | (878)† |
| Loss on disposal of property and equipment | 16† | 19† | 7 | 190† | 3† | 247† | 14 | 17† |
| Impairment charges | 0† | — | — | 43,254† | 0† | — | — | 0† |
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | 5,226† | (23,178)† | (45,609) | 47,187† | 4,135† | (14,717)† | (41,125) | 59,118† |
| Accounts payable | (4,804)† | 980† | (2,510) | 4,522† | (10,968)† | (255)† | (2,069) | 1,526† |
| Accrued expenses | 114,826† | 72,256† | (199,320) | 88,403† | 83,375† | 57,843† | (182,590) | 52,580† |
| Non-cash write-offs | — | — | — | — | (1,396)† | — | — | 0† |
| Restructuring accrual | (456)† | (461)† | (964) | (484)† | (1,396)† | 4,386† | — | — |
| Deferred revenue | (2,343)† | 1,628† | 4,347 | 5,109† | 1,836† | (2,624)† | 1,951 | 3,657† |
| Income taxes recoverable and payable, net | 2,328† | (11,471)† | 1,846 | 11,979† | (5,021)† | 645† | 4,723 | (13,309)† |
| Retirement and pension plan assets and liabilities | (701)† | (702)† | 6,732 | (364)† | 585† | 347† | 5,453 | 796† |
| Prepaid expenses | (1,346)† | 4,097† | (4,673) | (1,479)† | 595† | 3,339† | (7,991) | 5,004† |
| Other assets and liabilities, net | (2,524)† | (3,976)† | (10,393) | 2,609† | 5,022† | (2,913)† | (3,096) | 8,979† |
| Net cash used in operating activities | 134,679† | 68,610† | (232,224) | 176,793† | 101,145† | 62,522† | (203,424) | 153,825† |
| Cash flows - investing activities | ||||||||
| Acquisition of businesses, net of cash acquired | — | — | — | 0† | 0† | 0† | 0 | (11,905)† |
| Capital expenditures | (5,501)† | (3,906)† | (2,734) | (3,273)† | 6,891† | (10,365)† | (6,173) | (3,814)† |
| Purchases of marketable securities and investments | (66,089)† | (177,487)† | (118,719) | (48,003)† | (346)† | (109,862)† | (5,400) | (65,518)† |
| Proceeds from sales of marketable securities and investments | 183,408† | 104,106† | 48,325 | 46,237† | 62,496† | 289† | 66,285 | 48,183† |
| Net cash used in investing activities | 111,818† | (77,287)† | (73,128) | (5,039)† | 69,041† | (119,938)† | 54,712 | (33,054)† |
| Cash flows - financing activities | ||||||||
| Debt issuance costs | 0† | 0† | (360) | — | 0† | 0† | — | — |
| Cash dividends paid | (3,258)† | (3,251)† | (3,196) | (3,314)† | (3,211)† | (3,182)† | (3,216) | (3,154)† |
| Payment of employee tax withholdings on equity transactions | (317)† | (887)† | (2,889) | (17)† | (53)† | (885)† | (2,862) | 0† |
| Repurchases of common stock | — | — | — | 0† | 0† | — | — | 0† |
| Acquisition earnout payments | — | — | — | 0† | 0† | 0† | 0 | 2,038† |
| Net cash used in financing activities | (3,575)† | (4,138)† | (6,445) | (3,331)† | (3,264)† | (4,067)† | (6,078) | (1,116)† |
| Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash | 545† | 12,119† | 8,122 | (16,032)† | 6,578† | (1,426)† | (4,997) | 6,492† |
| Net decrease in cash, cash equivalents and restricted cash | 243,467† | (696)† | (303,675) | 152,391† | 173,500† | (62,909)† | (159,787) | 126,147† |
| Cash, cash equivalents and restricted cash at beginning of period | 211,442 | 212,138 | 515,813 | 363,422 | 189,922 | 252,831 | 412,618 | 286,471 |
| Cash, cash equivalents and restricted cash at end of period | 454,909 | 211,442 | 212,138 | 515,813 | 363,422 | 189,922 | 252,831 | 412,618 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.